Published in Environ Health Perspect on December 01, 1998
Endocrine disruptors and human health--is there a problem? An update. Environ Health Perspect (2000) 2.29
Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect (2007) 1.95
Problems for risk assessment of endocrine-active estrogenic compounds. Environ Health Perspect (2002) 1.11
Estradiol uptake, toxicity, metabolism, and adverse effects on cadmium-treated amphibian embryos. Environ Health Perspect (2004) 0.80
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet (1993) 12.83
Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04
The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect (1995) 5.37
The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect (1994) 3.12
Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect (1993) 3.07
Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet (1997) 2.95
The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet (1976) 2.63
Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol (1994) 2.62
Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect (1995) 1.79
Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol (1995) 1.75
Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol (1997) 1.75
Reproductive biology. Another DDT connection. Nature (1995) 1.56
Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect (1995) 1.42
Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35
Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control (1995) 1.27
Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology (1997) 1.16
Structure-activity relationships of estrogens. Environ Health Perspect (1985) 1.15
Steroid hormones and risk of breast cancer. Cancer (1994) 1.04
Potency of combined estrogenic pesticides. Science (1997) 1.04
Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene. Mol Cell Biol (1990) 0.94
Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol. Toxicol Appl Pharmacol (1997) 0.92
Pesticide residues and breast cancer: the harvest of a silent spring? J Natl Cancer Inst (1993) 0.92
Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer. Alcohol Clin Exp Res (1993) 0.90
The phytoestrogen congeners of alcoholic beverages: current status. Proc Soc Exp Biol Med (1995) 0.85
Molecular organization of the human cathepsin D gene. DNA Cell Biol (1991) 0.82
The phytoestrogens present in de-ethanolized bourbon are biologically active: a preliminary study in a postmenopausal woman. Alcohol Clin Exp Res (1991) 0.79
Growth inhibitory and antimitogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells. Toxicol Lett (1992) 0.79
Separation and identification of phytoestrogenic compounds isolated from bourbon. Alcohol Alcohol Suppl (1987) 0.78
Biologically active phytoestrogens are present in bourbon. Alcohol Clin Exp Res (1987) 0.78
Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol (1997) 10.61
Visualizing an olfactory sensory map. Cell (1996) 8.79
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell (1991) 7.40
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci U S A (1989) 6.32
Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect (1998) 6.08
A novel receptor-mediated nuclear protein import pathway. Cell (1996) 6.04
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci U S A (1987) 5.68
Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science (1995) 5.65
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 5.60
The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell (1997) 5.28
Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J (1992) 5.23
Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol (1988) 4.55
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene (2012) 4.30
Conduction at domain walls in oxide multiferroics. Nat Mater (2009) 4.18
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med (1990) 3.93
Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm. Mol Cell (2000) 3.86
Two-headed binding of a processive myosin to F-actin. Nature (2000) 3.73
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol (1987) 3.58
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J Biol Chem (2000) 3.37
Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J Virol (1991) 3.24
Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. J Virol (1990) 3.24
The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem (1992) 3.13
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med (1998) 3.13
Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv Ophthalmol (1992) 3.00
Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res (1999) 2.84
Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol (2006) 2.79
Epstein-Barr virus infection and replication in a human epithelial cell system. Nature (1992) 2.62
Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family. Proc Natl Acad Sci U S A (1986) 2.62
Population genetic implications from sequence variation in four Y chromosome genes. Proc Natl Acad Sci U S A (2000) 2.62
Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products. Trends Cell Biol (2000) 2.59
Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst (2000) 2.53
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res (2007) 2.49
Retention times and electron-capture detector responses of some individual chlorobiphenyls. Bull Environ Contam Toxicol (1972) 2.46
Generation and assembly of secretory antibodies in plants. Science (1995) 2.45
The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med (1990) 2.40
The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol (1998) 2.36
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation (1999) 2.36
alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors. J Pharmacol Exp Ther (1998) 2.33
Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells. J Virol (1986) 2.28
A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J Virol (1988) 2.27
Factors affecting movement of F-actin filaments propelled by skeletal muscle heavy meromyosin. Am J Physiol (1992) 2.25
Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet (2010) 2.20
Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol (1998) 2.18
Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure (1998) 2.17
Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. J Virol (1991) 2.16
Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev (2000) 2.15
Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem (2000) 2.00
Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme. J Gen Physiol (1999) 1.92
Differential modulation of proliferation in the neocortical ventricular and subventricular zones. J Neurosci (2000) 1.89
Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol (1997) 1.87
An animal model for acute and persistent Epstein-Barr virus infection. Science (1997) 1.85
Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res (1994) 1.85
Methicillin-resistant Staphylococcus aureus from China characterized by digestion of total DNA with restriction enzymes. Epidemiol Infect (1989) 1.85
An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science (1993) 1.81
Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health (1996) 1.80
Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene (2012) 1.80
The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. J Virol (1995) 1.79
Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol (2000) 1.77
An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons. Neuron (1998) 1.76
Genistein potentiates wild-type and delta F508-CFTR channel activity. Am J Physiol (1997) 1.72
Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. Mol Endocrinol (1992) 1.71
Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol Pathol (1998) 1.70
Malthusian models and Chinese realities: the Chinese demographic system, 1700-2000. Popul Dev Rev (1999) 1.69
Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J Virol (1996) 1.67
Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res (1996) 1.66
The cardiac anesthesia risk evaluation score: a clinically useful predictor of mortality and morbidity after cardiac surgery. Anesthesiology (2001) 1.66
Thyroid disorders in systemic lupus erythematosus. Ann Rheum Dis (1986) 1.66
Immunosuppressive and monooxygenase induction activities of polychlorinated diphenyl ether congeners in C57BL/6N mice: quantitative structure-activity relationships. Toxicol Appl Pharmacol (1990) 1.65
Three-dimensional dental model analysis of treatment outcomes for protrusive maxillary dentition: comparison of headgear, miniscrew, and miniplate skeletal anchorage. Am J Orthod Dentofacial Orthop (2008) 1.64
Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology (1993) 1.63
Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A (2000) 1.62
Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Toxicol Appl Pharmacol (1997) 1.61
Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene (2011) 1.60
Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J Virol (1989) 1.60
Rings of anionic amino acids as structural determinants of ion selectivity in the acetylcholine receptor channel. Proc Biol Sci (1991) 1.59
Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol (1999) 1.57
Flk-1 as a target for tumor growth inhibition. Cancer Res (1996) 1.56
Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem (2001) 1.55
A ring of uncharged polar amino acids as a component of channel constriction in the nicotinic acetylcholine receptor. FEBS Lett (1991) 1.53
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol (2007) 1.52
Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem Biol Interact (1993) 1.52
A case-control study of risk factors for playground injuries among children in Kingston and area. Inj Prev (1998) 1.52
Formation of precise connections in the olfactory bulb occurs in the absence of odorant-evoked neuronal activity. Neuron (2000) 1.52
Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem (1999) 1.50
Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus (1995) 1.50
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol (1995) 1.49
Polychlorinated biphenyls: metabolic behavior of pure isomers in pigeons, rats, and brook trout. Science (1972) 1.48
Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res (1997) 1.48
Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J Virol (2000) 1.46
Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery. Aliment Pharmacol Ther (2012) 1.45
Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci U S A (2000) 1.45
Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol Lett (1998) 1.44
The effect of environment on the free and hydrosoluble sterols of Mucor rouxii. Biochim Biophys Acta (1973) 1.44
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis. Pancreatology (2005) 1.43
Assessing sediment contamination in estuaries. Environ Toxicol Chem (2001) 1.43